The Claim

In patients with atherosclerotic cardiovascular disease who are already on statin therapy and have baseline LDL cholesterol levels of at least 70 mg/dL, the addition of evolocumab results in a 59% reduction in LDL cholesterol levels over 48 weeks, lowering median LDL-C from 92 mg/dL to 30 mg/dL, demonstrating that PCSK9 inhibition can achieve very low LDL-C levels in high-risk patients receiving standard lipid-lowering treatment.

Source: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
74score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
2 studies reviewed
In plain English

For people with heart disease who are already taking cholesterol-lowering pills, adding a drug called evolocumab can slash their bad cholesterol by about 60% in less than a year—bringing it down to very low levels.

See the scientific wording

In patients with atherosclerotic cardiovascular disease who are on statin therapy and have baseline LDL cholesterol levels of at least 70 mg/dL, adding evolocumab reduces LDL cholesterol levels by approximately 59% over 48 weeks, lowering median LDL-C from 92 mg/dL to 30 mg/dL, demonstrating that PCSK9 inhibition can achieve very low LDL-C levels in high-risk patients already receiving standard lipid-lowering treatment.

What the research says

2 studies

  1. Study: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    The study tested adding evolocumab to statins in heart disease patients and found it lowered bad cholesterol by 59%, just as claimed.

  2. Study: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    The study tested adding evolocumab to statins in heart disease patients and found it lowered bad cholesterol by 59%, just as claimed.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.